MTNB logo

MTNB CAPEX

Annual CAPEX

$218.00 K
-$674.00 K-75.56%

December 31, 2023


Summary


Performance

MTNB CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMTNBcash flowmetrics:

Quarterly CAPEX

N/A

September 30, 2024


Summary


Performance

MTNB Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMTNBcash flowmetrics:

TTM CAPEX

N/A

September 30, 2024


Summary


Performance

MTNB TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMTNBcash flowmetrics:

MTNB CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-75.6%--
3 y3 years+3724.6%--
5 y5 years-59.3%--

MTNB CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-75.6%at low
5 y5-year-75.6%+3724.6%
alltimeall time-76.9%+3724.6%

Matinas BioPharma Holdings CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$218.00 K(-75.6%)
-
-
Dec 2022
$892.00 K(+243.1%)
$42.00 K(-83.2%)
$892.00 K(+0.7%)
Sep 2022
-
$250.00 K(+354.5%)
$885.80 K(+3.0%)
Jun 2022
-
$55.00 K(-89.9%)
$860.00 K(+6.8%)
Mar 2022
-
$545.00 K(+1422.3%)
$805.00 K(+209.6%)
Dec 2021
$260.00 K(+4461.4%)
$35.80 K(-84.0%)
$260.00 K(+16.0%)
Sep 2021
-
$224.20 K(>+9900.0%)
$224.20 K(+3833.3%)
Dec 2020
$5700.00(-98.6%)
$0.00(0.0%)
$5700.00(0.0%)
Sep 2020
-
$0.00(0.0%)
$5700.00(-92.8%)
Jun 2020
-
$0.00(-100.0%)
$79.10 K(-80.1%)
Mar 2020
-
$5700.00(>+9900.0%)
$397.00 K(-2.1%)
Dec 2019
$405.60 K
$0.00(-100.0%)
$405.50 K(0.0%)
Sep 2019
-
$73.40 K(-76.9%)
$405.50 K(-33.2%)
DateAnnualQuarterlyTTM
Jun 2019
-
$317.90 K(+2138.7%)
$607.40 K(+35.5%)
Mar 2019
-
$14.20 K(>+9900.0%)
$448.20 K(-16.4%)
Dec 2018
$535.90 K(-43.1%)
$0.00(-100.0%)
$535.90 K(-18.1%)
Sep 2018
-
$275.30 K(+73.5%)
$654.20 K(+58.4%)
Jun 2018
-
$158.70 K(+55.7%)
$413.10 K(-60.4%)
Mar 2018
-
$101.90 K(-13.9%)
$1.04 M(+10.8%)
Dec 2017
$942.20 K(+1136.5%)
$118.30 K(+245.9%)
$942.20 K(+14.4%)
Sep 2017
-
$34.20 K(-95.7%)
$823.90 K(+4.3%)
Jun 2017
-
$789.70 K(+3348.5%)
$789.70 K(+937.7%)
Dec 2015
$76.20 K
$22.90 K(+57.9%)
$76.10 K(+43.0%)
Sep 2015
-
$14.50 K(-57.2%)
$53.20 K(+37.5%)
Jun 2015
-
$33.90 K(+606.3%)
$38.70 K(+706.3%)
Mar 2015
-
$4800.00
$4800.00

FAQ

  • What is Matinas BioPharma Holdings annual capital expenditures?
  • What is the all time high annual CAPEX for Matinas BioPharma Holdings?
  • What is Matinas BioPharma Holdings annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Matinas BioPharma Holdings?
  • What is the all time high TTM CAPEX for Matinas BioPharma Holdings?

What is Matinas BioPharma Holdings annual capital expenditures?

The current annual CAPEX of MTNB is $218.00 K

What is the all time high annual CAPEX for Matinas BioPharma Holdings?

Matinas BioPharma Holdings all-time high annual capital expenditures is $942.20 K

What is Matinas BioPharma Holdings annual CAPEX year-on-year change?

Over the past year, MTNB annual capital expenditures has changed by -$674.00 K (-75.56%)

What is the all time high quarterly CAPEX for Matinas BioPharma Holdings?

Matinas BioPharma Holdings all-time high quarterly capital expenditures is $789.70 K

What is the all time high TTM CAPEX for Matinas BioPharma Holdings?

Matinas BioPharma Holdings all-time high TTM capital expenditures is $1.04 M